Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Spero Therapeutics, Inc. - Common Stock (NQ:SPRO)

2.285 +0.085 (+3.86%)
Streaming Delayed Price Updated: 11:42 AM EDT, Aug 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 95,628
Open 2.210
Bid (Size) 2.280 (2)
Ask (Size) 2.290 (8)
Prev. Close 2.200
Today's Range 2.210 - 2.300
52wk Range 0.5052 - 3.220
Shares Outstanding 52,571,813
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For August 12, 2025
 
Via Benzinga
Earnings Outlook For Spero Therapeutics
 
Via Benzinga

Performance

YTD
+111.6%
+111.6%
1 Month
-13.4%
-13.4%
3 Month
+274.6%
+274.6%
6 Month
+187.1%
+187.1%
1 Year
+77.1%
+77.1%

More News

Read More
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
An Overview of Spero Therapeutics's Earnings
Via Benzinga
A Glimpse of Spero Therapeutics's Earnings Potential
Via Benzinga
The Analyst Verdict: Spero Therapeutics In The Eyes Of 4 Experts
Via Benzinga
Unusual volume stocks in Friday's session
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
These stocks are making the most noise in today's session.
Via Chartmill
Small-Cap Movers Under $1: HIT, SPRO, SGN, PRSO, SGBX Drive Momentum Across AI, Biotech, Crypto, Software, Etc.
Via AB Newswire
Topics Artificial Intelligence
What 4 Analyst Ratings Have To Say About Spero Therapeutics
Via Benzinga
Spero Therapeutics's Earnings Outlook
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Gains 2%; Macy's Lowers Earnings Forecast
Via Benzinga
Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday?
Via Benzinga
US Stocks Gain; Abercrombie & Fitch Posts Upbeat Earnings
Via Benzinga
GSK, Spero Therapeutics Stop Antibiotic Trial For Complicated Urinary Tract Infections Early After Positive Results, Retail’s Thrilled
Via Stocktwits
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 27, 2025
Via Benzinga
Earnings Scheduled For May 13, 2025
Via Benzinga
Earnings Scheduled For November 14, 2024
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Spero Therapeutics, Inc. - Common Stock publicly traded?
Yes, Spero Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Spero Therapeutics, Inc. - Common Stock trade on?
Spero Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Spero Therapeutics, Inc. - Common Stock?
The ticker symbol for Spero Therapeutics, Inc. - Common Stock is SPRO on the Nasdaq Stock Market
What is the current price of Spero Therapeutics, Inc. - Common Stock?
The current price of Spero Therapeutics, Inc. - Common Stock is 2.285
When was Spero Therapeutics, Inc. - Common Stock last traded?
The last trade of Spero Therapeutics, Inc. - Common Stock was at 08/12/25 11:42 AM ET
What is the market capitalization of Spero Therapeutics, Inc. - Common Stock?
The market capitalization of Spero Therapeutics, Inc. - Common Stock is 120.13M
How many shares of Spero Therapeutics, Inc. - Common Stock are outstanding?
Spero Therapeutics, Inc. - Common Stock has 120M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.